| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |